文献
J-GLOBAL ID:202002275085565841
整理番号:20A0795880
新たに診断された血管内大細胞型B細胞リンパ腫(PRIMEUR-IVL)に対する高用量メトトレキサート+髄腔内化学療法と併用したリツキシマブ,シクロホスファミド,ドキソルビシン,ビンクリスチンおよびプレドニゾロン:多施設,単腕,第2相試験【JST・京大機械翻訳】
Rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisolone combined with high-dose methotrexate plus intrathecal chemotherapy for newly diagnosed intravascular large B-cell lymphoma (PRIMEUR-IVL): a multicentre, single-arm, phase 2 trial
著者 (35件):
Shimada Kazuyuki
(Department of Hematology and Oncology, Nagoya University Graduate School of Medicine, Nagoya, Japan)
,
Yamaguchi Motoko
(Department of Hematology and Oncology, Mie University Graduate School of Medicine, Tsu, Japan)
,
Atsuta Yoshiko
(Japanese Data Center for Hematopoietic Cell Transplantation, Nagoya, Japan)
,
Matsue Kosei
(Division of Hematology/Oncology, Internal Medicine, Kameda Medical Center, Kamogawa, Japan)
,
Sato Keijiro
(Department of Hematology, Nagano Red Cross Hospital, Nagano, Japan)
,
Kusumoto Shigeru
(Department of Hematology and Oncology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan)
,
Nagai Hirokazu
(Department of Hematology, National Hospital Organization Nagoya Medical Center, Nagoya, Japan)
,
Takizawa Jun
(Department of Hematology, Endocrinology and Metabolism, Niigata University Faculty of Medicine, Niigata, Japan)
,
Fukuhara Noriko
(Department of Hematology and Rheumatology, Tohoku University Hospital, Sendai, Japan)
,
Nagafuji Koji
(Division of Hematology and Oncology, Department of Medicine, Kurume University School of Medicine, Kurume, Japan)
,
Miyazaki Kana
(Department of Hematology and Oncology, Mie University Graduate School of Medicine, Tsu, Japan)
,
Ohtsuka Eiichi
(Department of Hematology, Oita Prefectural Hospital, Oita, Japan)
,
Okamoto Masataka
(Department of Hematology, Fujita Health University School of Medicine, Toyoake, Aichi, Japan)
,
Sugita Yasumasa
(Department of Hematology, Oami Municipal Hospital, Oamishirasato, Japan)
,
Uchida Toshiki
(Department of Hematology and Oncology, Japanese Red Cross Nagoya Daini Hospital, Nagoya, Japan)
,
Kayukawa Satoshi
(Department of Clinical Oncology, Nagoya Memorial Hospital, Nagoya, Japan)
,
Wake Atsushi
(Department of Hematology, Toranomon Hospital Kajigaya, Kawasaki, Japan)
,
Ennishi Daisuke
(Department of Hematology and Oncology, Okayama University Hospital, Okayama, Japan)
,
Kondo Yukio
(Department of Internal Medicine, Toyama Prefectural Central Hospital, Toyama, Japan)
,
Izumi Tohru
(Division of Hematology, Tochigi Cancer Center, Utsunomiya, Japan)
,
Kin Yoshihiro
(Department of Hematology, Daini Osaka Police Hospital, Osaka, Japan)
,
Tsukasaki Kunihiro
(Department of Hematology, National Cancer Center Hospital East, Kashiwa, Chiba, Japan)
,
Hashimoto Daigo
(Department of Hematology, Hokkaido University Faculty of Medicine, Graduate School of Medicine, Sapporo, Japan)
,
Yuge Masaaki
(Division of Hematology, Ichinomiya Municipal Hospital, Ichinomiya, Japan)
,
Yanagisawa Atsumi
(Japanese Data Center for Hematopoietic Cell Transplantation, Nagoya, Japan)
,
Kuwatsuka Yachiyo
(Japanese Data Center for Hematopoietic Cell Transplantation, Nagoya, Japan)
,
Kuwatsuka Yachiyo
(Department of Advanced Medicine, Nagoya University Hospital, Nagoya, Japan)
,
Shimada Satoko
(Department of Pathology and Clinical Laboratories, Nagoya University Hospital, Nagoya, Japan)
,
Masaki Yasufumi
(Department of Hematology and Immunology, Kanazawa Medical University, Uchinada, Japan)
,
Niitsu Nozomi
(International Medical Center, Saitama Medical University, Hidaka, Japan)
,
Kiyoi Hitoshi
(Department of Hematology and Oncology, Nagoya University Graduate School of Medicine, Nagoya, Japan)
,
Suzuki Ritsuro
(Department of HSCT Data Management and Biostatistics, Nagoya University School of Medicine, Nagoya, Japan)
,
Tokunaga Takashi
(Department of Hematology, National Hospital Organization Nagoya Medical Center, Nagoya, Japan)
,
Nakamura Shigeo
(Department of Pathology and Clinical Laboratories, Nagoya University Hospital, Nagoya, Japan)
,
Kinoshita Tomohiro
(Division of Hematology and Cell Therapy, Aichi Cancer Center, Nagoya, Japan)
資料名:
Lancet Oncology
(Lancet Oncology)
巻:
21
号:
4
ページ:
593-602
発行年:
2020年
JST資料番号:
W1266A
ISSN:
1470-2045
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
オランダ (NLD)
言語:
英語 (EN)